We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current TTNP market cap is 3.66M. The company's latest EPS is USD -6.0914 and P/E is -0.66.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 83k | 3k | 0 | 0 | 0 |
Operating Income | -1.59M | -2.06M | -1.93M | -1.06M | -2.07M |
Net Income | -1.59M | -338k | -1.97M | -1.06M | -2.09M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 3.61M | 4.84M | 1.53M | 557k | 184k |
Operating Income | -16.84M | -7.35M | -9.35M | -10.24M | -7.28M |
Net Income | -16.46M | -18.24M | -8.78M | -10.21M | -5.57M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 812k | 10M | 8.09M | 6.65M | 4.35M |
Total Liabilities | 1.85M | 1.87M | 1.44M | 559k | 356k |
Total Equity | -1.03M | 8.13M | 6.64M | 6.09M | 3.99M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 9.52M | 8.09M | 7.99M | 4.06M | 8.09M |
Total Liabilities | 8.09M | 4.56M | 2.86M | 2.7M | 1.44M |
Total Equity | 1.43M | 3.53M | 5.14M | 1.36M | 6.64M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -3.01M | -4.85M | -7.09M | -613k | -2.68M |
Investing | N/A | 228k | 732k | N/A | N/A |
Financing | N/A | 9.59M | 10M | N/A | N/A |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -15.45M | -17.2M | -7.9M | -8.18M | -7.09M |
Investing | -256k | -540k | -23k | N/A | 732k |
Financing | 11.77M | 17.93M | 8.84M | 4.98M | 10M |
Market Cap | 3.66M |
Price to Earnings Ratio | -0.66 |
Price to Sales Ratio | 19.87 |
Price to Cash Ratio | 0.54 |
Price to Book Ratio | 0.55 |
Dividend Yield | - |
Shares Outstanding | 914.23k |
Average Volume (1 week) | 7.01k |
Average Volume (1 Month) | 8.99k |
52 Week Change | -58.86% |
52 Week High | 14.80 |
52 Week Low | 3.565 |
Spread (Intraday) | 0.5 (12.47%) |
Company Name | Titan Pharmaceuticals Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.titanpharm.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions